TABLE 3

Pharmacokinetic parameters of β-lactam antibiotics in humans




Mol. Wt.

Dose

CLtotal

Xurine

References
mg ml/min/kg % dose
Cefoperazone 645 1000a 2.14 40.0 Chemotherapy27 (Suppl 6):369-384, 1980 (in Japanese)
Cefbuperazone 627 1000a 1.08 92.5 Chemotherapy30 (Suppl 3):640-661, 1982 (in Japanese)
Cefpiramide 612 1000a 0.26 25.2 Chemotherapy31 (Suppl 1):144-157, 1983 (in Japanese)
Cefotetan 576 1000a 0.41 83.0 Chemotherapy30 (Suppl 1):163-173, 1982 (in Japanese)
Ceftriaxone 554 1000a 0.26 54.3 Chemotherapy32 (Suppl 7):98-125, 1984 (in Japanese)
Cefotiam 525 500a 6.21 78.9 Chemotherapy27 (Suppl 3):192-200, 1979 (in Japanese)
Cefmetazole 471 1000a 1.76 83.9 Chemotherapy26 (Suppl 5):145-154, 1978 (in Japanese)
Cefamandole 462 1000a 3.45 96.7 Chemotherapy27 (Suppl 5):135-144, 1979 (in Japanese)
Cefazolin 454 500a 1.29 81.9 Chemotherapy24:811-823, 1976 (in Japanese)
Cefixime 453 100a 0.98 64.8 Jpn J Clin Pharmacol Ther17:559-568, 1986 (in Japanese)
Ceftezole 440 500a 3.34 88.8 Chemotherapy24:811-823, 1976 (in Japanese)
Cefuroxime 424 500a 1.97 83.0 Biopharm Drug Dispos8:519-526, 1987
Cefdinir 395 200b N.A. 23.0 Antimicrob Agents Chemother39:1082-1086, 1995
Cephalexin
347
250b
N.A.
88.7
Biopharm Drug Dispos17:319-330, 1996
  • N.A., not applicable.

  • a Intravenous administration.

  • b Oral administration.